Treatment options

The aim of treating stable COPD is to immediately relieve and reduce the impact of symptoms as well as reduce the risk of future exacerbations.1 According to the Global Strategy for the Diagnosis, Management and Prevention of COPD1 all patients who smoke should be encouraged to quit.

The guide also states that the mainstays of treatment are pharmacologic therapy with bronchodilators and corticosteroids, with patients at all stages of the disease benefiting from pulmonary rehabilitation programs.

Supplementary oxygen may be recommended in COPD patients with chronic respiratory failure who have severe resting hypoxemia, as a measure to improve blood oxygen levels.1

Oxygen and COPD

Oxygen and COPD

Evidence shows that long‐term oxygen therapy (LTOT) can benefit patients with COPD. A Cochrane review of randomised controlled trials found LTOT improved survival in COPD patients with severe hypoxemia.

NIV in treating COPD

Recent studies have shown that home non-invasive ventilation (NIV) using adequate pressure support in stable hypercapnic COPD patients can reduce the number of hospitalisations and improve mortality

NIV in treating COPD

NIV in treating COPD

Recent studies have shown that home non-invasive ventilation (NIV) using adequate pressure support in stable hypercapnic COPD patients can reduce the number of hospitalisations and improve mortality

iVAPS in treating COPD

iVAPS in treating COPD

ResMed’s Intelligent Volume Assured Pressure Support (iVAPS) therapy targets alveolar ventilation, improving gas exchange and reducing CO₂ levels in hypercapnic patients.

Our products

Through our range of homecare ventilators ResMed is committed to improving quality of life for COPD patients. Several NIV systems are available for use by COPD patients in the home.

Our products

Our products

Through our range of homecare ventilators ResMed is committed to improving quality of life for COPD patients. Several NIV systems are available for use by COPD patients in the home.